These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17362704)

  • 1. Late bleeding problems with the levonorgestrel-releasing intrauterine system: evaluation of the endometrial cavity.
    Rönnerdag M; Odlind V
    Contraception; 2007 Apr; 75(4):268-70. PubMed ID: 17362704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Length of the endometrial cavity and intrauterine contraceptive device expulsion.
    Bahamondes MV; Monteiro I; Canteiro R; Fernandes Ados S; Bahamondes L
    Int J Gynaecol Obstet; 2011 Apr; 113(1):50-3. PubMed ID: 21272883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
    Pakarinen P; Luukkainen T
    Contraception; 2005 Nov; 72(5):342-5. PubMed ID: 16246659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
    Oliveira-Ribeiro M; Petta CA; De Angelo Andrade LA; Bahamondes L; Hidalgo MM
    Hum Reprod; 2004 Aug; 19(8):1778-84. PubMed ID: 15192067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
    Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding: a 6- and 12-month morphological and clinical follow-up.
    Palmara V; Sturlese E; Villari D; Giacobbe V; Retto A; Santoro G
    Aust N Z J Obstet Gynaecol; 2013 Aug; 53(4):381-5. PubMed ID: 23701372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery.
    Jones RL; Critchley HO
    Hum Reprod; 2000 Aug; 15 Suppl 3():162-72. PubMed ID: 11041232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
    Hickey M; Fraser IS
    Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception.
    Tariq N; Ayub R; Jaffery T; Rahim F; Naseem F; Kamal M
    J Coll Physicians Surg Pak; 2011 Apr; 21(4):210-3. PubMed ID: 21453616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium.
    Roopa BA; Loganath A; Singh K
    Hum Reprod; 2003 Sep; 18(9):1809-19. PubMed ID: 12923132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
    Selim MF; Hussein AF
    Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.